Making vaccines more effective

September 19, 2012 by Catherine Somerville
Dr Irina Caminschi.

(Medical Xpress)—Scientists have discovered an important mechanism in which a synthetic DNA targets the immune system that could significantly improve the effectiveness of future vaccines.

This was published today in the (PNAS) journal.

Burnet Institute Centre for Immunology Laboratory Head, Dr Irina Caminschi, has identified for the first time a new receptor (DEC-205) that binds to the (known as CpG),

"CpG is very immune-stimulatory, it makes the immune system more reactive, which is why it is used in vaccines. It is currently in clinical trials for cancer and malaria vaccines," Dr Caminschi said.

"While testing it for various immune responses, we discovered a mechanism that elicits that very strong reaction."

Though researchers have used CpG to enhance immune responses, it was unknown which receptor the used to actually grab the DNA and internalise it for recognition.

"Essentially by understanding how the immune system recognises this foreign, synthetic DNA and the rules that govern this recognition, we can exploit it so that when it gets used in a vaccine it works better," Dr Caminschi said.

Explore further: Manipulating the immune system to develop 'next-gen' vaccines

Related Stories

Manipulating the immune system to develop 'next-gen' vaccines

April 5, 2012

The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by 'tricking' cells into launching an immune response, leading to next-generation vaccines that are more specific, ...

Scientists discover new 'off switch' in immune response

February 28, 2012

Scientists from Trinity College Dublin have discovered a new 'off switch' in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. The findings ...

Recommended for you

When liver immune cells turn bad

April 21, 2017

A high-fat diet and obesity turn "hero" virus-fighting liver immune cells "rogue", leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.

Researchers unlock an immunity 'black box'

April 18, 2017

A research team led by St. Jude Children's Research Hospital immunologists has revealed a previously unknown immune machinery that goes awry to trigger the inflammatory disease neutrophilic dermatosis. Neutrophilic dermatoses ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.